Bcl-2 Family Inhibitors

Bcl-2

Bcl-xL

Bcl-W

Mcl-1

Bfl-1

Bcl-B

Bax

Bak

Bim

BNIP3

Bad

Bcl-2 Family Inhibitors, Agonists, Antagonists, Activators, Modulators, Inducers, Degraders & Ligands

Product Name	Bcl-2	Bcl-xL	Bcl-W	Mcl-1	Bfl-1	Bcl-B	Bax	Bak	Bim	BNIP3	Bad	Purity
Venetoclax	Bcl-2, Ki: 0.01 nM	Bcl-xL, Ki: 48 nM	Bcl-W, Ki: 245 nM									99.95%
Sorafenib	Bcl-2	Bcl-xL										99.85%
Polyinosinic-polycytidylic acid	Bcl-2						Bax					99.40%
2-Tetralone			Bcl-W									99.85%
DIM-3,5-Cl2	Bcl-2											99.18%
Navitoclax	Bcl-2, Ki: 1 nM	Bcl-xL, Ki: 1 nM	Bcl-W, Ki: 1 nM									99.97%
Sulforaphane							Bax					99.75%
ABT-737	Bcl-2, EC₅₀: 30.3 nM	Bcl-xL, EC₅₀: 78.7 nM	Bcl-W, EC₅₀: 197.8 nM	Mcl-1, EC₅₀: >10 μM	Bfl-1, EC₅₀: >10 μM	Bcl-B, EC₅₀: 1820 nM						99.64%
S63845				MCL1, Kd: 0.19 nM								99.94%
Beta-Sitosterol (purity>98%)	Bcl-2						Bax					99.74%
A-1331852	Bcl-2, Ki: 6 nM	Bcl-xL, Ki: 0.01 nM	Bcl-W, Ki: 4 nM	Mcl-1, Ki: 142 nM								99.93%
BT2				Mcl-1, Ki: 59 μM								99.81%
Estradiol benzoate							Bax					99.90%
BAI1							Bax					99.89%
AZD-5991				Mcl-1, IC₅₀: 0.7 nM Mcl-1, Kd: 0.17 nM								99.79%
Benzbromarone	Bcl-2											99.91%
Sorafenib tosylate	Bcl-2	Bcl-xL										99.98%
Digitoxin	Bcl-2						Bax					99.22%
A-1155463	Bcl-2, Ki: 80 nM	Bcl-xL, Ki: 0.01 nM										99.60%
Amantadine	Bcl-2						Bax					99.90%
MRT68921	Bcl-2											98.09%
MIK665				Mcl-1, IC₅₀: 1.81 nM								99.11%
Gossypol	Bcl-2, Ki: 0.2-0.3 mM	Bcl-xL, Ki: 0.5-0.6 μM										99.67%
Poly (I:C):Kanamycin (1:1)	Bcl-2						Bax
Obatoclax Mesylate	Bcl-2, Ki: 220 nM	Bcl-xL, Ki: 1-7 μM	Bcl-W, Ki: 1-7 μM	Mcl-1, Ki: 1-7 μM		Bcl-B, Ki: 1-7 μM						99.85%
Gambogic Acid	Bcl-2, IC₅₀: 1.21 μM	Bcl-xL, IC₅₀: 1.47 μM	Bcl-W, IC₅₀: 2.02 μM	Mcl-1, IC₅₀: 0.79 μM	Bfl-1, IC₅₀: 1.06 μM	Bcl-B, IC₅₀: 0.66 μM						98.34%
Bax inhibitor peptide V5							Bax					99.90%
Dihydrocapsaicin	Bcl-2	Bcl-xL					Bax					99.93%
MRT68921 dihydrochloride	Bcl-2											99.67%
Carboxymethyl chitosan	Bcl-2						Bax
UMI-77	Bcl-2, Ki: 23.83 μM	Bcl-xL, Ki: 32.99 μM	Bcl-W, Ki: 8.19 μM	Mcl-1, Ki: 0.49 μM	Bfl-1, Ki: 5.33 μM							99.66%
Dehydrocorydaline	Bcl-2						Bax					99.77%
AVN-944							Bax	Bak				99.89%
TCPOBOP	Bcl-2											99.70%
AZD4320	BCL2, IC₅₀: 17 nM (KPUM-UH1 cells)	BCLxL, IC₅₀: 17 nM (KPUM-UH1 cells)										99.66%
Deltamethrin	Bcl-2						Bax					99.93%
AS 1411	Bcl-2											99.52%
Lisaftoclax	Bcl-2, IC₅₀: 2 nM	Bcl-xL, IC₅₀: 5.9 nM										99.78%
MSN-125							Bax	Bak				99.00%
Glutamic acid sodium salt	Bcl-2											99.92%
AS 1411 sodium	Bcl-2											99.52%
Amantadine hydrochloride	Bcl-2						Bax					98.0%
(R)-Sulforaphane							Bax					99.95%
A-1210477	Bcl-2, Ki: 132 nM		Bcl-W, Ki: 2280 nM	Mcl-1, Ki: 0.45 nM	Bfl-1, Ki: 660 nM							99.86%
WEHI-539 hydrochloride		Bcl-xL, IC₅₀: 1.1 nM										99.72%
Co(III) protoporphyrin IX chloride	Bcl-2
Fezakinumab	Bcl-2											99.9%
GM-90257	Bcl-2											99.90%
Gossypol (acetic acid)	Bcl-2, Ki: 0.2-0.3 mM	Bcl-xL, Ki: 0.5-0.6 μM										99.75%
Peiminine	Bcl-2											99.89%
Paris saponin VII	Bcl-2											99.84%
Triclabendazole	Bcl-2						Bax					99.36%
Pyraclostrobin	Bcl-2						Bax					99.91%
(E)-Ferulic acid							Bax					99.82%
Corynoline	Bcl-2											98.84%
N-Hydroxyphthalimide		Bcl-xL										99.89%
BTSA1							Bax, IC₅₀: 250 nM Bax, EC₅₀: 144 nM					99.77%
Humanin							Bax					99.73%
DEG-77							Bax					99.03%
Jaceosidin							Bax					99.51%
MSN-50							Bax	Bak				98.09%
Ganoderma Lucidum/Reishi Extract	Bcl-2	Bcl-xL
S55746	Bcl-2, Ki: 1.3 nM Bcl-2, Kd: 3.9 nM	Bcl-xL, Ki: 520 nM Bcl-xL, Kd: 186 nM										99.91%
PROTAC Mcl1 degrader-1	Bcl-2, IC₅₀: 0.54 μM			Mcl-1, IC₅₀: 0.78 μM								98.13%
PROTAC Bcl2 degrader-1	Bcl-2, DC₅₀: 3 μM Bcl-2, IC₅₀: 4.94 μM			Mcl-1, IC₅₀: 11.81 μM								99.80%
Navitoclax-piperazine		Bcl-xL										99.73%
Poly-L-lysine hydrobromide (MW 30000-70000)	Bcl-2						Bax
BMS-195614	BCL2											99.5%
Tapotoclax				Mcl-1, Ki: 0.13 nM								99.53%
Bz 423							Bax	Bak				99.72%
TC11				MCL1								99.55%
L6H21	Bcl-2						Bax					99.19%
Stem bromelain	Bcl-2						Bax
(R)-(-)-Gossypol	Bcl-2, Ki: 260 nM	Bcl-xL, Ki: 480 nM		Mcl-1, Ki: 170 nM								99.37%
Anti-Mouse 4-1BB/CD137 Antibody (3H3)		Bcl-xL
TW-37	Bcl-2, Ki: 290 nM	Bcl-xL, Ki: 1110 nM		Mcl-1, Ki: 260 nM								99.50%
ML281											bad	98.04%
Bim-IN-1									Bim			99.57%
Sabutoclax	BCL2, IC₅₀: 0.32 μM	Bcl-xL, IC₅₀: 0.31 μM		Mcl-1, IC₅₀: 0.2 μM	Bfl-1, IC₅₀: 0.62 μM							99.80%
VU0661013				Mcl-1								98.45%
Methyl caffeate	Bcl-2						Bax					99.89%
Daphnoretin	Bcl-2						Bax					99.83%
Vanillyl alcohol	Bcl-2						Bax					99.68%
Rhein 8-O-β-D-Glucopyranoside	Bcl-2											99.81%
Secoxyloganin	Bcl-2											99.33%
Rehmannioside A	Bcl-2											99.96%
Nivalenol							Bax					99.24%
Triptophenolide							Bax	Bak	Bim			99.98%
CLZ-8				Mcl-1, Ki: 0.3 μM								99.14%
BH3I-1	Bcl-2	Bcl-xL						Bak	Bim			98.0%
SYM 2081	Bcl-2						Bax					98.0%
(S)-Gossypol (acetic acid)	Bcl-2	Bcl-xL										98.46%
Grosvenorine	Bcl-2											99.64%
XZ739		Bcl-xL, DC₅₀: 2.5 nM										99.08%
PZ671		Bcl-xL										98.70%
HA14-1	Bcl-2, IC₅₀: 9 μM											98.0%
BAX-IN-1							Bax					98.05%
Ginsenoside Rh4							Bax					99.28%
PROTAC Bcl-xL degrader-2		Bcl-xL, IC₅₀: 0.6 nM										98.23%
(R)-(-)-Gossypol acetic acid	Bcl-2, Ki: 260 nM	Bcl-xL, Ki: 480 nM		Mcl-1, Ki: 170 nM								98.93%
BM-1197	Bcl-2, IC₅₀: 3.5 nM	Bcl-xL, IC₅₀: 5.2 nM										99.48%
PZ703b		Bcl-xL										98.00%
MCL-1/BCL-2-IN-1	Bcl-2, IC₅₀: 3.18 μM			Mcl-1, IC₅₀: 4.45 μM								98.65%
Caudatin	Bcl-2	Bcl-xL					Bax				bad	99.95%
Puerarin 6''-O-Xyloside	Bcl-2						Bax					99.81%
23-Hydroxybetulinic acid	Bcl-2						Bax					99.44%
BRD-810				MCL1, Kd: 0.3 nM								98.00%
NKP608	Bcl-2						Bax					99.88%
4-Ethylphenyl sulfate	Bcl-2						Bax
MIM1				Mcl-1								98.0%
Ciwujianoside B	Bcl-2						Bax					99.68%
PUMA BH3								Bak, Kd: 26 nM				98.24%
ML311				Mcl-1					Bim			98.98%
A-385358	Bcl-2, Ki: 67 nM	Bcl-xL, Ki: 0.8 nM
Murizatoclax				MCL1, Ki: 15 pM								98.84%
GL0388							Bax					98.03%
dMCL1-2				MCL1, Kd: 30 nM								99.29%
MM41	Bcl-2											98.89%
Mcl-1 inhibitor 6	Bcl-2, Kd: >10 μM Bcl2A1, Kd: >10 μM Bcl-2, Ki: 10 μM	Bcl-xL, Kd: >10 μM	Bcl-W, Kd: >10 μM	Mcl-1, Kd: 0.23 nM Mcl-1, Ki: 0.02 μM	Bfl-1, Ki: 1.57 μM							98.77%
BAM7							Bax, IC₅₀: 3.3 μM					99.20%
BDA-366	Bcl-2, Ki: 3.3 nM											98.42%
Apoptotic agent-3	Bcl-2						Bax					98.19%
Isolinderalactone	Bcl-2											98.79%
Thevetiaflavone	Bcl-2						Bax					99.83%
Maritoclax				Mcl-1, IC₅₀: 10.1 μM								99.97%
Pim-1 kinase inhibitor 2	Bcl-2						Bax					99.91%
PBX-7016				Mcl-1
MNK8	Bcl-2											99.76%
SMBA1							Bax, Ki: 43.3 nM					99.5800%
Salvianolic acid D	Bcl-2						Bax
Glycocholic acid hydrate	Bcl-2						Bax
YX0798				Mcl-1								98.90%
Damulin B	Bcl-2
WEHI-3773							Bax	Bak				99.89%
MLS-0053105	Bcl-2/F-Bim, IC₅₀: 12.5 μM	Bcl-XL/F-Bim, IC₅₀: 50 μM	Bcl-W/F-Bim, IC₅₀: 12.5 μM		Bfl-1/F-Bid, IC₅₀: 0.4 μM							98.89%
Obatoclax	BCL2, Ki: 200 nM	Bcl-xL, Ki: 1-7 μM	Bcl-W, Ki: 1-7 μM	Mcl-1, Ki: 1-7 μM		Bcl-B, Ki: 1-7 μM						≥99.0%
Cardanol monoene	Bcl-2						Bax					98.02%
Bfl-1-IN-2					Bfl-1, IC₅₀: 4.3 μM							99.76%
AZD-5991 (S-enantiomer)				Mcl-1, IC₅₀: 6.3 μM Mcl-1, Kd: 0.98 μM								99.83%
CYD-4-61							Bax
Destruxin B	Bcl-2											99.86%
Aspidin BB	Bcl-2						Bax					98.02%
Haplophytin-A	Bcl-2	Bcl-xL
Hexamethylquercetagetin	Bcl-2											98.0%
S55746 hydrochloride	Bcl-2, Ki: 1.3 nM Bcl-2, Kd: 3.9 nM	Bcl-xL, Ki: 520 nM Bcl-xL, Kd: 186 nM										99.66%
Apogossypolone	Bcl-2, Ki: 35 nM	Bcl-xL, Ki: 660 nM		Mcl-1, Ki: 25 nM								98.58%
FCN-338	BCL2											99.33%
AZD-5991 Racemate				Mcl-1, IC₅₀: 3 nM
Procyanidin B2-3'-O-gallate	Bcl-2	Bcl-xL
IMB-XH1				Mcl-1								98.0%
BCL-XL-IN-3		BCLxL, Ki: <0.01 nM
(+)-Apogossypol	Bcl-2, EC₅₀: 2.8 μM	Bcl-xL, EC₅₀: 3.69 μM		Mcl-1, EC₅₀: 2.6 μM
BBR-BODIPY							Bax					98.15%
BPA-B9	Bcl-2			Mcl-1								98.50%
n-Butyl-β-D-fructofuranoside	Bcl-2						Bax
Shinpterocarpin	Bcl-2						Bax
PTD10	Bcl-2
XYD049	Bcl-2											99.46%
Anticancer agent 43							Bax					98.58%
WX2-43							Bax					98.74%
PZ703b TFA		Bcl-xL										98.62%
Bax activator-1							Bax					98.45%
Apoptosis inducer 19	Bcl-2						Bax					98.31%
AF151	Bcl-2			Mcl-1								98.87%
Mcl1-IN-1				Mcl-1, IC₅₀: 2.4 μM								98.02%
WEHI-539		Bcl-xL, IC₅₀: 1.1 nM
Pyridoclax				Mcl-1								99.95%
Mcl1-IN-9				Mcl-1, Ki: 0.03 nM
A-1210477-piperazinyl				MCL1
Bcl-2-IN-2	Bcl-2, IC₅₀: 0.034 nM	Bcl-xL, IC₅₀: 43 nM
(E)-Mcl-1 inhibitor 7				Mcl-1, Ki: <10 nM Mcl-1, IC₅₀: <500 nM
Mcl-1 inhibitor 3				Mcl-1, IC₅₀: 19 nM Mcl-1, Ki: 0.061 nM
Amantadine sulfate	Bcl-2						Bax
BM 957	Bcl-2, IC₅₀: 5.4 nM Bcl-2, Ki: 1.2 nM	Bcl-xL, IC₅₀: 6.0 nM Bcl-xL, Ki: <1 nM
FKL-137	Bcl-2						Bax
Mcl-1 inhibitor 12				Mcl-1, Ki: 0.22 nM
Trijuganone C							Bax
Scoulerine hydrochloride								Bak
c-MYC/BCL2 ligand 1 iodide	Bcl-2, Kd: 0.56 μM
Nordentatin				Mcl-1
G-quadruplex ligand 4	Bcl-2
CDK4/6-IN-28	BCL2
Meayamycin B				Mcl-1
Jaceosidin (Standard)							Bax
Bcl-2-IN-10							Bax
MS1 peptide	Bcl-2
CDK9-IN-45				Mcl-1
Mcl-1-IN-17				Mcl-1, Ki: <0.08 nM
Bcl-2-IN-23	Bcl-2
QNX-10		Bcl-xL					Bax
3-Tridecylphenol		Bcl-xL		Mcl-1
Antitumor agent-77	Bcl-2						Bax
2-Methoxyjuglone	Bcl-2						Bax
Bcl-2-IN-4	Bcl-2, IC₅₀: 1.5 nM	Bcl-xL, IC₅₀: 411 nM
ZLMT-72				Mcl-1
eIF4E/eIF4G PPI-IN-1	Bcl-2
Mcl-1-IN-16				Mcl-1, Ki: < 0.08 nM
Lobetyol	Bcl-2						Bax
Mcl-1-IN-20	Bcl-2, Ki: 3.6 μM	Bcl-xL, Ki: 6.6 μM		Mcl-1, Ki: 0.59 μM
FMP							Bax
Avicin D	Bcl-2
8α-Tigloyloxyhirsutinolide 13-O-acetate	Bcl-2	Bcl-xL		Mcl-1
Metuzumab	Bcl-2						Bax
MHY219	Bcl-2						Bax
CPA-7		Bcl-xL		Mcl-1
PROTAC Bcl-xL degrader-3		Bcl-xL
A09-003				Mcl-1
YVPGP		Bcl-xL					Bax
TYMJ-01	Bcl-2
G721-0282	Bcl-2											99.96%
TRP-601	Bcl-2
IKKβ-IN-7	Bcl-2	Bcl-xL					Bax
Bcl-2/Mcl-1-IN-5	Bcl-2			Mcl-1
WR-S-462	Bcl-2	BCLxL
Bcl-2/Mcl-1-IN-2	Bcl-2, Ki: 4.70 μM			Mcl-1, Ki: 0.88 μM
BRD4 Inhibitor-15	Bcl-2						Bax
Topo I/DDX5-IN-1	Bcl-2
ZSNI-21	Bcl-2						Bax
TFSeB	Bcl-2						Bax
Antitumor agent-78	Bcl-2						Bax
Calactin	Bcl-2						Bax
EGFR/BRAFV600E-IN-2	Bcl-2						Bax
JNJ-4355				Mcl-1, Ki: 18 pM
TBC1D2-IN-1	Bcl-2						Bax
Gymnoside II	Bcl-2	Bcl-xL
Apoptosis inducer 44	Bcl-2						Bax
Icterogenin		Bcl-xL
PROTAC BRD4 Degrader-42							Bax
BM-1074	Bcl-2, IC₅₀: 1.8 nM	Bcl-xL, IC₅₀: 6.9 nM
EMT inhibitor-3	Bcl-2						Bax
Apoptotic agent-2	Bcl-2						Bax
CT20p							Bax
DNH28	Bcl-2						Bax
ST09							Bax
NSC 373981	BCL2
EGFR-IN-197		Bcl-xL
XAN-5	Bcl-2						Bax				bad
Bcl-2-IN-9	Bcl-2, IC₅₀: 2.9 μM (^[1])
CG-1521							Bax
Mcl-1-IN-22				Mcl-1, Ki: 0.015 μM
EGFR-IN-187	Bcl-2						Bax
Cytisine-platinum(IV) prodrug-1	Bcl-2						Bax
JAK1/2-IN-3	Bcl-2						Bax
Tambulin	Bcl-2						Bax
VEGFR-2-IN-70							Bax
Topoisomerase II/EGFR-IN-2	Bcl-2						Bax
Bcl-2-IN-11	Bcl-2, IC₅₀: 0.9 nM	Bcl-xL, IC₅₀: >1000 nM
KRAS G12D-IN-37	Bcl-2						Bax
PI3K/mTOR-IN-19	Bcl-2						Bax
Ferroptosis/apoptosis inducer-5	Bcl-2						Bax
Topo I/II-IN-3							Bax
STAT3-IN-46	Bcl-2
EGFR/CDK2-IN-5	Bcl-2						Bax
MLS-2384 free base				Mcl-1
Bid BH3-Gly-r8	Bcl-2						Bax
PI3K-IN-58	Bcl-2	Bcl-xL					Bax
Apoptosis inducer 43	Bcl-2						Bax
Bcl-2/Mcl-1-IN-4	Bcl-2, Ki: 0.49 μM			Mcl-1, Ki: 0.51 μM
STAT3/NF-κB-IN-1	Bcl-2						Bax
LSD1-IN-26	Bcl-2
Topoisomerase I inhibitor 17	Bcl-2						Bax
Mcl-1-IN-21				Mcl-1
Bcl-2/Mcl-1-IN-1	Bcl-2, Ki: 4.53 μM			Mcl-1, Ki: 1.19 μM
MN33-63	Bcl-2
MRT68921 hydrochloride	Bcl-2
α-D-Manp(3→1)-α-D-Manp(2→1)-α-D-Glu	Bcl-2						Bax
Anticancer agent 64	Bcl-2						Bax
EGFR/VEGFR2-IN-9	Bcl-2						Bax
Apoptosis inducer 39	Bcl-2
Bcl-2-IN-5	Bcl-2, IC₅₀: 0.12 nM
Stigmast-5-en-3-ol		Bcl-xL					Bax
Candidone	Bcl-2						Bax
Mcl-1 inhibitor 13				Mcl-1, Ki: 8.2 nM
HSP70-IN-6									Bim
Mcl-1-IN-22 hydrochloride				Mcl-1, Ki: 0.015 μM
iMPZ-8	Bcl-2						Bax
CAIX/CDK-2-IN-1	Bcl-2						Bax
PROTAC HDAC3 degrader-1		Bcl-xL		Mcl-1
MA203		Bcl-xL					Bax
STAT3-IN-44	Bcl-2
Bcl-2-IN-6	Bcl-2						Bax
Apoptosis inducer 45	Bcl-2						Bax
PI3K/mTOR-IN-22	Bcl-2						Bax
VEGFR/PD-L1-IN-1	Bcl-2						Bax
Multi-kinase-IN-7	Bcl-2						Bax
Bcl-2/Mcl-1-IN-3	Bcl-2, Ki: 0.23 μM	Bcl-xL, Ki: 15 μM		Mcl-1, Ki: 0.14 μM
SC-60	Bcl-2
METTL3-IN-11	Bcl-2
BW-AQ-113	Bcl-2						Bax
MNK1/2-IN-11				Mcl-1
Bcl-2-IN-7	Bcl-2						Bax
4-Hydroxyresveratrol							Bax
PROTAC Bcl-xL degrader-1		Bcl-xL
Dimethyl bisphenolate	Bcl-2								Bim
BChE-IN-49	Bcl-2						Bax
BCL-XL-IN-4	Bcl-2, Ki: 170 nM	Bcl-xL, Ki: 0.042 nM
Santamarine	Bcl-2						Bax					98.85%
PROTAC BCL-xL/BCL-w Degrader 1		Bcl-xL	Bcl-W
Anticancer agent 201	Bcl-2	Bcl-xL
Astin B	Bcl-2						Bax
GQN-B37-E				Mcl-1, Ki: 0.6 μM
TKL002	Bcl-2						Bax
β-Eleostearic acid	Bcl-2
COX/5-LO-IN-2	Bcl-2						Bax
EGFR-IN-109	Bcl-2						Bax
CDK1/2/4-IN-1	Bcl-2						Bax
HDAC-IN-91	Bcl-2						Bax
6-Ethyl-7-hydroxy-4-methyl-2H-chromen-2-one				Mcl-1, Ki: 5.47 μM Mcl-1, IC₅₀: 30.88 μM
PZ-11											bad
Dehydrobruceine B	Bcl-2	Bcl-xL					Bax
EGFR/BRAFV600E-IN-6	Bcl-2						Bax
p53 DUBTAC modulator-1	Bcl-2
PROTAC ATR degrader-3	Bcl-2
CHNQD-01522							Bax
EGFR-IN-201	Bcl-2						Bax
EGFR-IN-134	Bcl-2						Bax
CDK9-IN-44				MCL1
Cephalotaxine-ester-(R)-1-ethoxy-3-mercaptopropan-2-ol-Ph(3,4OMe)				Mcl-1
YC137	Bcl-2, Ki: 1.3 μM	Bcl-xL, Ki: >100 μM
STAT3-IN-51	Bcl-2
Chuanbeinone	Bcl-2						Bax
Mito-fisetin mF7	Bcl-2
NSC 850745	Bcl-2
EGFR-IN-170	Bcl-2						Bax
MAPK-IN-5	Bcl-2
Anticancer agent 306	Bcl-2						Bax
PZ703b hydrochloride		Bcl-xL										99.18%
BI1071	Bcl-2
CSN5-IN-3	Bcl-2
Topo I/II-IN-2	Bcl-2						Bax
SP-6-27							Bax
Tubulin polymerization-IN-85	Bcl-2	Bcl-xL		Mcl-1			Bax				bad
PARP1-IN-50	Bcl-2						Bax
JS04	Bcl-2	Bcl-xL
anti-TNBC agent-3	Bcl-2
Antioxidant agent-22	Bcl-2						Bax
ERK5-IN-7	Bcl-2						Bax
PI3K/mTOR-IN-17	Bcl-2						Bax
ICD inducer-2	Bcl-2						Bax		Bim
XSJ151	Bcl-2						Bax
BRD4-IN-12	Bcl-2
Tubulin polymerization-IN-88		Bcl-xL
Anticancer agent 65	Bcl-2						Bax
Apoptosis inducer 50		Bcl-xL					Bax		Bim
Caylin-2		Bcl-xL										99.0%
HDAC-IN-93	Bcl-2						Bax
GPER/Bcl-2-IN-1	Bcl-2
Anticancer agent 63	Bcl-2
FKA-9i	Bcl-2
Furowanin A				Mcl-1
Apoptosis inducer 56	Bcl-2						Bax
PROTAC PI3K/110β degrader-2	Bcl-2						Bax
FLC-8	Bcl-2						Bax				bad
MN33-47	Bcl-2
MB725							Bax
Bfl-1-IN-7					Bfl-1, IC₅₀: 0.015 μM
A-371191	Bcl-2, Ki: 40 μM	Bcl-xL, Ki: <0.5 μM	Bcl-W, Ki: 180 μM			Bcl-B, Ki: 1300 μM
RU28362										BNIP3
PUMA BH3 TFA								Bak, Kd: 26 nM
NGI-189									Bim			99.29%
Spicamycin	Bcl-2
VEGFR-2/AKT-IN-2	Bcl-2
PROTAC Bcl-xL degrader-4	Bcl-2	Bcl-xL
Bcl-2-IN-3	Bcl-2
(-)BI97D6	Bcl-2, IC₅₀: 0.031 μM	Bcl-xL, IC₅₀: 0.076 μM		Mcl-1, IC₅₀: 0.025 μM
Longan cerebroside II	Bcl-2						Bax
Sphingosine	Bcl-2	Bcl-xL					Bax
BDE30671203	Bcl-2
Triptophenolide (Standard)							Bax	Bak	Bim
Bax agonist 1							Bax, Ki: 57.2 nM
Thaspine acetate							Bax	Bak
N-Hydroxyphthalimide (Standard)		Bcl-xL
Myrothecine A							Bax
BCL-xL ligand 3		Bcl-xL
Vanillyl alcohol (Standard)	Bcl-2						Bax
YCW-E11	Bcl-2			Mcl-1
Mcl1-IN-15				Mcl-1, IC₅₀: 8.73 μM
TM-233				Mcl-1
Bak BH3		Bcl-xL

Name
Email *

	Sorry, but the email address you supplied was invalid.